A breath for health: An exploratory study in severe asthma patients in Turkey

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 9, 2008, Pages 1218-1227

  Bavbek, S ^a   Misirligil, Z ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Limitations of asthma; Patient's perspective; Patients' opinion; Severe asthma

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; THEOPHYLLINE DERIVATIVE;

ADULT; ARTICLE; ASTHMA; ATOPY; CHRONIC DISEASE; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG PREFERENCE; DRUG SENSITIVITY; DRUG USE; EXPECTATION; FEMALE; GOVERNMENT; HEALTH CARE; HEALTH CARE QUALITY; HERBAL MEDICINE; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT CARE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RHINOSINUSITIS; SOCIAL ASPECT; TABLET; TURKEY (BIRD);

ACTIVITIES OF DAILY LIVING; ADULT; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 49249132487     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01706.x     Document Type: Article

References (31)

1. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self- reported asthma attacks, and use of asthma medication in the European community respiratory health survey (ECRHS). Eur Respir J 1996 9: 687 696.
2. Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G et al. Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med 2006 100: 140 147.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Revised 2006; available at http://www.ginasthma.org.
4. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Publication No. 97-4051. Bethesda: National Heart, Lung and Blood Institutes of Health, 1997.
5. Bayindir Ü, Erkan P, Kalyonai F, Misirligil Z, Türktus H. National Asthma Diagnosis and Treatment Guideline (in Turkish). Toraks Dergisi 2000 Supp. 1 1 32.
6. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004 114: 40 47.
7. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J 2000 16: 802 807.
8. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002 110: 58 64.
9. Barnes PJ, Johnson B, Klim JB. The costs of asthma. Eur Respir J 1996 9: 636 642.
10. Dockrell M, Partridge MR, Valovirta E. The limitations of severe asthma: the results of a European survey. Allergy 2007 62: 134 141.
11. Wenzel SE, Busse WW, The National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Severe asthma: lessons from the severe asthma research program. J Allergy Clin Immunol 2007 119: 14 21.
12. Çelik G, Mungan D, Bavbek S, Sin B, Demirel YS, Misirligil Z. The prevalence of allergic diseases and atopy in Ankara, Turkey. A two-step population based epidemiological study. J Asthma 1999 36: 281 290.
13. Saraclar Y, Çetinkaya F, Tuncer A et al. The prevalence of self-reported asthma and respiratory symptoms in Ankara, Turkey. Respir Med 1997 91: 461 463.
14. Bavbek S, Çelik G, Ediger D, Mungan D, Sin B, Demirel YS et al. Severity and associated risk factors in adult asthmatic patients in Turkey. Ann Allergy Asthma Immunol 2000 85: 134 139.
15. Çelik GE, Bavbek S, Mungan D, Pasaoǧlu G, Abadoǧlu Ö, Harmanci E et al. Direct medical cost of asthma in Ankara, Turkey. Respiration 2004 7: 587 593.
16. Sekerel BE, Gemicioglu B, Soriano JB. Asthma insights and reality in Turkey (AIRET) study. Respir Med 2006 100: 1850 1854.
17. Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006 141: 189 198.
18. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007 120: 396 402.
19. Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 2007 2: 655 660.
20. Caress AL, Beaver K, Luker K, Campbell M, Woodcock A. Involvement in treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey. Thorax 2005 60: 199 205.
21. Yawn BP, van der Molen T, Humbert M. Asthma management: are GINA guidelines appropriate for daily clinical practice? Prim Care Respir J 2005 14: 294 302.
22. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006 61: 663 709.
23. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, Fitzgerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 31: 143 178.
24. Barnes PJ. Introduction: how can we improve asthma management? Curr Med Res Opin 2005 4: S1 S3.
25. Lemiere C, Boulet LP. Cigarette smoking and asthma: a dangerous mix. Can Respir J 2005 12: 79 80.
26. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006 174: 127 133.
27. Ernst E. Complementary therapies in asthma: what patients use. J Asthma 1998 35: 667 671.
28. Kurt E, Bavbek S, Pasaoǧlu G, Abadoǧlu Ö, Misirligil Z. Use of alternative medicines by allergic patients in Turkey. Allergol Immunopathol 2004 32: 289 294.
29. Wenzel SE. A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma. Eur Respir J 2003 22: 397 398.
30. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicenter study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003 22: 470 477.
31. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world evaluation of asthma control and treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007 119: 1454 1461.